You could be making bigger gains!
When COVID first reared its head, the race for a vaccine was on. Moderna had been working on a new tech already (as had Pfizer) utilizing messenger RNA rather than the actual virus. Groundbreaking stuff. Of course, as traders, we began to perk up at Moderna’s *** in the markets. Interestingly, our artificial intelligence had already been showing Moderna as full of potential back in January, and we wrote about it for our traders (click here to see) as a demonstration of how artificial intelligence can help traders trade smarter.
Soon Moderna was on everyone’s radar as vaccines started rolling out to consumers in a race to save lives. This week over on our weekly Stock Study we publish every week for traders for free, we take another look at Moderna.
Here’s the basic chart including our patented, predictive blue line that traders using VantagePoint can access. As you can see, there’s been some volatility there.
For investors, looking at Moderna as a buy-and-hold opportunity, they did okay! 123.90% in 71 days of trading. Nothing to sneeze at…but along the way, they had to give back some of those profits when Moderna took a steep turn.
You know as a trader the hardest part of trading is timing! When do you get out and when do you get in? For the meek, the buy and hold strategy did okay but those downside losses weren’t necessary.
The traders who did really well with Moderna were swing traders using VantagePoint!
Take a look at this chart of how traders have used AI to do more than just ride the buy and hold trajectory. Using VantagePoint’s points of confirmation, traders know when to get out and when to hold on; and, even more important, when to get back in! Three easy trades made with confidence gave VantagePoint traders 134.87% gains without having to give money back in those downturns.
But that’s not the only benefit to VantagePoint Traders. They also have insight from our patented, global Intermarket Analysis which detects hidden patterns in the marketplace affecting price action. Here’s the chart for Moderna.
While VantagePoint traders are making considerable gains trading $MRNA, they also see they may want to look at Hormel, Smith & Wesson, Clorox, J. W. Smuckers, and Sprouts Farmers Market…because they are all tied to Moderna! Would you have guessed that?!
Some traders want to know the story behind that relationship. VantagePoint frees up your time so you can go investigate if you want to, but you don’t need to in order to start making gains from them; just review their forecasts/history to determine if they might be worthy of trading too.
Oh, and all of this information is available to you in the time it takes to type MRNA and click your mouse twice.
Welcome to a whole new way of trading!
Most of our traders need just 15 minutes each evening to set their trades for the following day – not with a hope and a prayer but with data-driven confidence and ever-increasing accuracy.
By the way, did you know we publish a stock study every week? You can read more about how our software helped traders make the most of Moderna’s charge up the charts here along with other examples that demonstrate why predictive artificial intelligence can change your trading and change your life!
One last reminder, if your trading hasn’t been as profitable as you wanted it to be – hot tip: it’s not you, it’s your tools.
Let’s fix that!
If you haven’t seen VantagePoint or you’re ready to become part of our Vantagepoint family, join us at a free training or email us to set up a personal, one-on-one demonstration and get a free forecast for the market of your choice.
And, VantagePoint traders, if you’d like to learn even more about your software, email us or access the schedule of our online trainings available to our entire Vantagepoint family through your customer portal.
